Does Ryze Coffee Help with Weight Loss? Honest Evidence Review

This evidence review is part of Weight Loss Rankings’ living editorial database — 1,100+ research articles and 600+ clinically-reviewed GLP-1 telehealth providers, sourced only from FDA prescribing information on DailyMed, primary product labels, and peer-reviewed PubMed literature.

The honest answer: no. There are zero published randomized controlled trials of the Ryze mushroom coffee formulation on body weight, body composition, or appetite, and the ingredient-level evidence on cordyceps, lion’s mane, reishi, turkey tail, shiitake, king trumpet, and MCT oil powder is mostly cognition, ergogenic, immune, or rodent data — not weight loss data. The brand itself does not claim Ryze causes weight loss on the official product page; the “Ryze for weight loss” framing comes from downstream TikTok and Instagram influencer marketing. The FDA has not evaluated Ryze for any indication. At best, swapping a 200–300 kcal sweetened latte for a ~30 kcal cup of Ryze produces a small calorie deficit consistent with any low-calorie beverage swap — the active ingredient is the calorie reduction, not the mushroom blend.

What Ryze actually is (a mushroom coffee blend, not a drug)

Per the Ryze Superfoods product page accessed May 2026 ^[7], the blend is sold as a daily coffee replacement in tablespoon-size servings (~6 g) mixed with hot water. The full ingredient list is:

• Organic arabica coffee
• Cordyceps mushroom extract
• Lion’s mane mushroom extract
• Reishi mushroom extract
• Turkey tail mushroom extract
• Shiitake mushroom extract
• King trumpet mushroom extract
• MCT oil powder
• Coconut milk powder

The mushroom blend is approximately 2 g of the 6 g total serving. The brand does not disclose individual gram amounts for each mushroom species — a common dietary supplement industry practice (the “proprietary blend” approach) that prevents consumers and reviewers from comparing per-mushroom doses against the doses used in clinical trials. Some flavored variants add cocoa, vanilla, or matcha.

Crucially, Ryze is regulated as a dietary supplement under the Dietary Supplement Health and Education Act of 1994 (DSHEA, codified at 21 U.S.C. §§ 321(ff), 343(r), 343-2, 350b)^[9]. Supplements do NOT undergo FDA pre-market review for safety or efficacy. The manufacturer is permitted to make structure/function claims (such as “supports focus” or “supports energy”) but is prohibited from making drug-disease claims — which is exactly what a weight-loss claim becomes when it crosses the line from “supports a healthy weight” into “causes weight loss.” The official Ryze product page is mostly compliant on this point; the issue is the downstream influencer-driven copy that pushes the weight-loss framing.

Caffeine content: ~48 mg vs ~95 mg in regular coffee

Ryze markets approximately 48 mg of caffeine per serving, roughly half of a standard 8-oz brewed coffee (~95 mg per USDA FoodData Central). This is a real product difference and may be welcomed by people who are caffeine- sensitive, who drink coffee later in the day, or who want to avoid the jitters of a stronger cup. It is also one of the more honest claims the brand makes — the lower-caffeine proposition does not require trial evidence to be true.

The lower caffeine is not, by itself, a weight-loss mechanism. Caffeine produces a small acute increase in resting energy expenditure — roughly 50–100 kcal/day in the dose range of 200–300 mg — and Ryze sits well below that threshold per serving. The FDA cites 400 mg/day as a generally safe ceiling for healthy adults^[8]. If anything, the lower caffeine in Ryze means less acute thermogenic effect than regular coffee, not more.

Ingredient-by-ingredient evidence (and what it does NOT show)

Each Ryze ingredient has its own evidence base. None of them supports a meaningful body-weight effect at the doses present in one serving. The table below summarizes the most rigorous evidence layer for each ingredient and what the trial primary outcome actually was.

Cordyceps: ergogenic claims, not weight loss

Cordyceps is primarily studied as a putative ergogenic aid — an exercise-performance enhancer — not as a weight-loss agent. The 2025 narrative review by Dewi and Khemtong in Current Nutrition Reports^[3] catalogued the human evidence on Cordyceps militaris and Cordyceps sinensis on VO2max, time-to-exhaustion, and recovery markers. The conclusion was that the trials are mixed, mostly small, often underpowered, and insufficient to recommend cordyceps for performance. None of the cordyceps trials reviewed measured body weight as a primary outcome. The TikTok “cordyceps for weight loss” claim is downstream pre-experimental marketing — the human cordyceps literature does not support it.

Lion’s mane: cognition data, not weight loss

The canonical lion’s mane (Hericium erinaceus) clinical reference is Mori 2009 in Phytotherapy Research^[2], a 16-week double-blind RCT in 30 Japanese adults aged 50–80 with mild cognitive impairment. The dose was 3 g/day of dried lion’s mane for 16 weeks, with the Hasegawa Dementia Scale-Revised as the primary cognition endpoint — not body weight, not appetite, not adiposity. The 2025 Menon systematic review in Frontiers in Nutrition ^[4] is the most recent comprehensive Hericium review and reports the same shape: cognition, mood, and gastrointestinal endpoints have small but heterogeneous signals; body weight is not a clinically meaningful endpoint in the published trial literature. The 3 g/day Mori dose is also roughly an order of magnitude above the lion’s mane extract present in one serving of Ryze.

Reishi, turkey tail, chaga, shiitake, king trumpet: no human weight RCTs

The remaining functional mushrooms in the Ryze blend (Ganoderma lucidum reishi, Trametes versicolor turkey tail, Inonotus obliquus chaga, Lentinula edodes shiitake, Pleurotus eryngii king trumpet) have evidence bases concentrated in:

• Reishi: immune-marker pilots, rodent obesity studies (e.g., Chang 2015 Nat Commun reported gut-microbiota effects on body weight in mice), and sleep-quality pilots in humans. No human RCT at the doses present in a single serving of Ryze reports a body-weight signal.
• Turkey tail: the PSK (polysaccharide-K) oncology adjunct literature from Japan, used as a chemotherapy adjuvant rather than for weight loss. The PSK doses are much higher than what is in a mushroom coffee blend.
• Chaga: antioxidant in vitro and small oxidative-stress-marker pilots. No human body-weight RCTs.
• Shiitake: lentinan-based immune-modulation and a small lipid-panel literature in humans. No body-weight RCT.
• King trumpet: in vitro and rodent lipid panel work. No human trials.

The honest framing: each of these mushrooms is a real food with real bioactive compounds and a plausible role in a well-rounded diet. None of them has human RCT evidence supporting weight loss at the doses present in a coffee blend.

MCT oil powder: the trial doses are 5–48 g, Ryze is a fraction of that

MCT (medium-chain triglyceride) oil is the one Ryze ingredient with a direct body-weight meta-analysis: Mumme and Stonehouse 2015 in the Journal of the Academy of Nutrition and Dietetics^[1] pooled 13 RCTs (n=749) testing dietary replacement of long-chain triglycerides with MCT. Pooled mean body weight reduction was approximately −0.51 kg — statistically significant but characterized by the authors as of borderline clinical relevance. The MCT doses in those trials ranged from 5 to 48 g/day. One serving of Ryze is ~6 g total across coffee, six mushroom extracts, MCT oil powder, and coconut milk powder; the MCT oil component is a small fraction of even the lowest-dose trial. The honest verdict: even if you assume the entire serving of Ryze were pure MCT (it is not), the dose is below the Mumme trial range, and the Mumme pooled effect is small.

Weight-loss claims debunked, one by one

The most common Ryze weight-loss claims circulating on TikTok and Instagram, and what the evidence actually says:

• “Ryze suppresses appetite like Ozempic.” False. There is no GLP-1 receptor agonist in Ryze; the ingredients act on unrelated pathways or have no documented appetite mechanism. For the full breakdown, see the GLP-1 OTC supplement scam evidence review .
• “Mushroom coffee boosts metabolism.” Caffeine modestly raises resting energy expenditure (~50– 100 kcal/day at 200–300 mg). Ryze contains ~48 mg caffeine — LESS than regular coffee. No metabolism boost beyond what you would get from a smaller cup of regular coffee.
• “Cordyceps burns fat during workouts.” The Dewi 2025 review^[3] found the human cordyceps + exercise literature mixed, underpowered, and insufficient. No fat-burning claim survives.
• “Lion’s mane suppresses cravings.” Lion’s mane has cognition data only^{[2] [4]}. There is no human appetite or craving endpoint in the trial literature.
• “Reishi balances cortisol and reduces belly fat.” No human RCT supports a reishi + belly fat outcome. The cortisol claim is extrapolated from small stress-biomarker pilots and rodent data.
• “MCT oil melts fat.” The most rigorous MCT meta-analysis (Mumme 2015^[1]) pooled to ~ −0.51 kg at 5–48 g/day. Ryze contains a fraction of the lowest-dose trial.
• “Turkey tail and chaga detox the gut and reduce bloating.” There is no human RCT evidence base for either claim at supplement doses. The PSK turkey tail literature is oncology adjunctive, not gut- detox.

Magnitude vs FDA-approved GLP-1 drugs

For the magnitude-of-effect reality check, the most rigorous weight-loss RCTs in adults with overweight or obesity:

The pharmacotherapy-vs-supplement gap is roughly 30x in documented magnitude, and the supplement side of the comparison is generous — Ryze itself has no RCT, and the MCT comparator is calculated at trial doses far above what Ryze provides. The honest framing: if weight loss is the actual goal and you have access to evidence-based pharmacotherapy, the magnitude difference is large enough that Ryze is not a serious comparator.

FDA stance on functional-mushroom and weight-loss marketing

Three facts about the regulatory landscape that consumers should keep in mind:

• FDA does NOT evaluate dietary supplements for efficacy. Under DSHEA 1994^[9], supplements are not subject to pre-market FDA review for either safety or efficacy. The manufacturer self-affirms safety. The FDA acts post-market on adverse events and mislabeling.
• Drug-disease claims are prohibited. A dietary supplement may make structure/function claims (“supports energy,” “supports focus”) but may NOT claim to “treat,” “cure,” or “prevent” a disease — including obesity. Marketing copy that promises percentage body weight reductions matching prescription drugs is grounds for an FDA Warning Letter.
• FTC enforcement on weight-loss claims has direct precedent. The FTC v. Cardiff (Redwood Scientific Technologies) case (172-3117-X190001, 2018 complaint, 2020 default judgment) is the most-cited federal precedent for false weight-loss claims on supplement-format products and applies equally to mushroom coffee marketing that pushes weight-loss claims without supporting clinical evidence.

What to do instead if you enjoy mushroom coffee

Ryze is not, on its face, an unsafe product — the labeled ingredients are real foods and recognized GRAS substances. The problem is the gap between the marketed weight-loss framing and the actual evidence. A reasonable consumer position:

• If you enjoy the taste and the lower caffeine, drink it. A ~30 kcal cup of Ryze is calorically similar to plain black coffee and substantially lower than a 200–300 kcal sweetened latte. The calorie reduction is a real benefit if it replaces a higher-calorie beverage.
• Do not expect Ozempic-magnitude or Wegovy-magnitude results. There is no published RCT of Ryze on body weight. The TikTok before-and-after posts are anecdotal, confounded by other concurrent diet and exercise changes, and not subject to placebo control.
• Anchor your actual weight-loss plan on the evidence-based levers. Calorie deficit, adequate protein at 1.2–1.6 g/kg/day, progressive resistance training, and — if appropriate — the FDA-approved anti-obesity pharmacotherapies. See our supplements vs GLP-1 evidence grade and our interactive supplement evidence grader tool for the broader picture.
• Be skeptical of influencer copy. The Ryze official product page itself avoids most prohibited drug-disease claims; the “weight loss” framing comes from TikTok and Instagram creators with affiliate relationships. Discount their claims accordingly.

How Ryze compares to other “wellness” weight-loss drinks

Ryze sits in a category of beverage products marketed as weight-loss aids without RCT evidence supporting the claim. The category includes apple cider vinegar drinks, green tea and EGCG extracts sold as fat-burners, “detox” teas with senna-based laxatives, and “metabolism booster” coffees with proprietary blends. Each shares a similar evidence shape:

• Apple cider vinegar: Launholt 2020 (Eur J Nutr) and Castagna 2025 (Nutrients) systematic reviews found inconsistent, limited evidence with high heterogeneity. Insufficient to recommend.
• Green tea / EGCG fat-burner extracts: the most rigorous Hursel meta-analyses found a pooled effect of ~ −1.3 kg over 12 weeks. Real but small; orders of magnitude below prescription GLP-1.
• “Detox” teas (senna-based): produce short-term water and stool weight loss via osmotic laxation; not fat loss; chronic use risks electrolyte imbalance.
• Mushroom coffee (Ryze, Four Sigmatic, MUD/WTR, etc.): no RCT-supported weight-loss claim at the dose served. Ingredient-level evidence concentrates on cognition, immune, or ergogenic endpoints — not weight.

The unifying pattern is that beverage-format weight-loss products lean on individual ingredient associations that evaporate when scrutinized at the actual product dose. For the broader debunker of OTC products marketed as “natural Ozempic” or “GLP-1 support,” see the GLP-1 OTC supplement scam evidence review . For the 16-ingredient evidence grade, see supplements vs GLP-1 evidence grade . For the “natural Ozempic” berberine claim specifically, see the berberine vs Ozempic deep dive .

Bottom line

• Zero published RCTs of the Ryze formulation on body weight, body composition, or appetite. The weight-loss claim cluster on TikTok and Instagram is pre-experimental marketing.
• Cordyceps has ergogenic data only^[3], mixed and underpowered. Lion’s mane has cognition data only ^[2][4]. Reishi, turkey tail, chaga, shiitake, and king trumpet have no human body-weight RCTs. MCT oil at trial doses (5–48 g/day) pooled to ~ −0.51 kg^[1] — Ryze is a fraction of that dose range.
• Caffeine in Ryze (~48 mg per serving) is less than half of regular coffee (~95 mg/8 oz). No thermogenic advantage over a smaller cup of plain coffee.
• DSHEA 1994^[9] prohibits drug-disease claims on dietary supplements; Ryze itself is mostly compliant on the official product page. The downstream influencer copy is the issue.
• Magnitude vs FDA-approved drugs: STEP-1 semaglutide ^[5] −14.9% body weight at 68 weeks; SURMOUNT-1 tirzepatide^[6] −20.9% at 72 weeks. No mushroom coffee approaches that magnitude.
• The honest verdict: drink Ryze if you enjoy it for the taste or the lower caffeine. Do not buy it for weight loss. The active ingredient in any successful “Ryze weight-loss” anecdote is the calorie reduction from swapping out a higher-calorie beverage, not the mushroom blend.

Frequently asked questions

Related research and tools

• GLP-1 OTC supplement scam evidence review — the sister debunker on “natural Ozempic” OTC products (berberine, capsaicin, fiber, chromium, apple cider vinegar). None act on the GLP-1 receptor; effect sizes are roughly 10x smaller than prescription GLP-1 drugs.
• Weight-loss supplements vs GLP-1: evidence grade — 16 of the most-searched OTC supplements graded against peer-reviewed RCT evidence and the magnitude of FDA-approved GLP-1 drugs.
• Berberine vs Ozempic: the “nature’s Ozempic” myth — the canonical deep-dive berberine review with the full PubMed evidence chain. Berberine is an AMPK activator, not a GLP-1 receptor agonist.
• Are mushrooms good for weight loss? — whole-food mushrooms (white button, shiitake, oyster) have real but modest evidence for energy-density substitution and umami satiety. That evidence base does NOT carry over to powdered mushroom extracts in a coffee blend.
• Ozempic and coffee: caffeine interaction evidence — for patients already on a GLP-1, what coffee (including mushroom coffee) does and does not do to drug effect.
• Supplement evidence grader (tool) — interactive evidence grader scoring OTC supplements on mechanism, RCT support, and magnitude vs FDA-approved GLP-1 drugs.
• Wegovy (semaglutide) — STEP-1 magnitude reference (−14.9% body weight at 68 weeks).
• Zepbound (tirzepatide) — SURMOUNT-1 magnitude reference (−20.9% body weight at 72 weeks).